Bleeding patterns of HIV-infected women using an etonogestrel-releasing contraceptive implant and efavirenz-based or lopinavir/ritonavir-based antiretroviral therapy

References

• Sedgh G, Singh S, Hussain R. Intended and unintended pregnancies worldwide in 2012 and recent trends. Stud Fam Plann. 2014;45:301–314.
   PubMed Web of Science ®Google Scholar
• Loufty MR, Raboud JM, Wong J, et al. High prevalence of unintended pregnancies in HIV-positive women of reproductive age in Ontario, Canada: a retrospective study. HIV Med. 2012;13:107–117.
   PubMed Web of Science ®Google Scholar
• Schwartz SR, Rees H, Mehta S, et al. High incidence of unplanned pregnancy after antiretroviral therapy initiation: findings from a prospective cohort study in South Africa. PLoS One. 2012;7:e36039.
   PubMed Web of Science ®Google Scholar
• Fiore S, Heard I, Thorne C, et al. Reproductive experience of HIV-infected women living in Europe. Hum Reprod. 2008;23:2140–2144.
   PubMed Web of Science ®Google Scholar
• Brandão K de S, Lima BG, Travassos AG, et al. Dual contraception adherence among HIV-infected women. Rev Bras Ginecol Obstet. 2015;37:486–491.
   PubMedGoogle Scholar
• Koenig LJ, Espinoza L, Hodge K, et al. Young, seropositive, and pregnant: epidemiologic and psychosocial perspectives on pregnant adolescents with human immunodeficiency virus infection. Am J Obstet Gynecol. 2007;197(3 Suppl.):S123–S131.
   PubMedGoogle Scholar
• Kenny J, Williams B, Prime K, et al. Pregnancy outcomes in adolescents in the UK and Ireland growing up with HIV. HIV Med. 2012;13:304–308.
   PubMed Web of Science ®Google Scholar
• Elgalib A, Hegazi A, Samarawickrama A, et al. Pregnancy in HIV-infected teenagers in London. HIV Med. 2011;12:118–123.
   PubMed Web of Science ®Google Scholar
• Tsui AO, McDonald-Mosley R, Burke AE. Family planning and the burden of unintended pregnancies. Epidemiol Rev. 2010;32:152–174.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Global monitoring framework and strategy for the global plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive (EMTCT). Geneva: WHO; 2012.
   Google Scholar
• Secura G, Madden T, Mc Nicholas C, et al. Provision of no-cost, long-acting contraception and teenage pregnancy. N Engl J Med. 2014;371:1316–1323.
   PubMed Web of Science ®Google Scholar
• O’Neil-Callahan M, Peipert JF, Zhao Q, et al. Twenty-four–month continuation of reversible contraception. Obstet Gynecol. 2013;122:1083–1091.
   PubMed Web of Science ®Google Scholar
• Winner B, Peipert JF, Zhao Q, et al. Effectiveness of long-acting reversible contraception. N Engl J Med. 2012;366:1998–2007.
   PubMed Web of Science ®Google Scholar
• Trussell J. Contraceptive failure in the United States. Contraception. 2011;83:397–404.
   PubMed Web of Science ®Google Scholar
• Darney P, Patel A, Rosen K, et al. Safety and efficacy of a single-rod etonogestrel implant (Implanon): results from 11 international clinical trials. Fertil Steril. 2009; 91:1646–1653.
   PubMed Web of Science ®Google Scholar
• Mansour D, Korver T, Marintcheva-Petrova M, et al. The effects of Implanon on menstrual bleeding patterns. Eur J Contracept Reprod Health Care. 2008;13(Suppl. 1):13–28.
   PubMed Web of Science ®Google Scholar
• Shulman LP. The state of hormonal contraception today: benefits and risks of hormonal contraceptives: combined estrogen and progestin contraceptives. Am J Obstet Gynecol. 2011;205(Suppl. 4):9–13S.
   Web of Science ®Google Scholar
• Vieira CS, Bahamondes MV, de Souza RM, et al. Effect of antiretroviral therapy including lopinavir/ritonavir or efavirenz on etonogestrel-releasing implant pharmacokinetics in HIV-positive women. J Acquir Immune Defic Syndr. 2014;66:378–385.
   PubMed Web of Science ®Google Scholar
• Secretaria de Vigilância em Saúde [Health Surveillance Secretariat]. Portaria SVS/MS N° 151; [cited 2009 May 5]. Available from: www.aids.gov.br/sites/default/files/portaria151_2009.pdf.
   Google Scholar
• World Health Organization. Medical eligibility criteria for contraceptive use. 4th ed. Geneva: WHO; 2009; [cited 2009 May 10]. Available from: http://whqlibdoc.who.int/publications/2010/9789241563888_eng.pdf.
   Google Scholar
• Ministério da Saúde [Ministry of Health]. Protocolo clínico e diretrizes terapêuticas para manejo da infecção pelo HIV em adultos [Clinical protocol and therapeutic guidelines for adults living with HIV/AIDS; [cited 2009 May 10]. Available from: www.aids.gov.br/sites/default/files/anexos/publicacao/2013/55308/protocolo_final_31_7_2015_pdf_30707.pdf.
   Google Scholar
• Belsey EM, Machin D, d'Arcangues C. The analysis of vaginal bleeding patterns induced by fertility regulating methods. World Health Organization Special Programme of Research, Development and Research Training in Human Reproduction. Contraception. 1986;34:253–260.
   PubMed Web of Science ®Google Scholar
• Rodriguez G, Faundes A, Atkinson LL. Focus on the analysis of menstrual patterns in the critical evaluation of contraceptives. Estud Poblac. 1976;1:90–107.
   PubMedGoogle Scholar
• Modesto W, Bahamondes MV, Bahamondes L. A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives. Hum Reprod. 2014;29:1393–1399.
   PubMed Web of Science ®Google Scholar
• Patel RC, Onono M, Gandhi M, et al. Pregnancy rates in HIV-positive women using contraceptives and efavirenz-based or nevirapine-based antiretroviral therapy in Kenya: a retrospective cohort study. Lancet HIV. 2015;2:e474–e482.
   PubMed Web of Science ®Google Scholar
• Hickey M, Fraser IS. Iatrogenic unscheduled (breakthrough) endometrial bleeding. Rev Endocr Metab Disord. 2012;13:301–308.
   PubMed Web of Science ®Google Scholar
• Mansour D, Bahamondes L, Critchley H, et al. The management of unacceptable bleeding patterns in etonogestrel-releasing contraceptive implant users. Contraception. 2011;83:202–210.
   PubMed Web of Science ®Google Scholar
• Bahamondes L, Brache V, Meirik O, et al. A 3-year multicenter randomized controlled trial of etonogestrel- and levonorgestrel-releasing contraceptive implants with non-randomized matched copper-intrauterine device controls. Hum Reprod. 2015;30:2527–2538.
   PubMed Web of Science ®Google Scholar
• Jeffreys LA, Clark AL. A successful approach to long-acting contraceptive implants in primary care. Contraception. 2012;85:381–383.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Consolidated guidelines on the use of anti-retroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. Geneva: WHO 2013; [cited 2016 March 16]. Available from: http://apps.who.int/iris/bitstream/10665/85321/1/9789241505727_eng.pdf.
   Google Scholar
• World Health Organization. Medical eligibility criteria for contraceptive use. 5th ed. Geneva: WHO 2015; [cited 2016 March 16]. Available from: www.who.int/reproductivehealth/publications/family_planning/MEC-5/en/.
   Google Scholar
• World Health Organization. WHO statement on progestogen-only implants. Accessed on 16 March 2016 from: www.who.int/reproductivehealth/publications/family_planning/statement-progestogen-implants/en/.
   Google Scholar